UBX-362

N/A

Report date: 2023/12/26 18:02:49

Base Information

Drug NameUBX-362

Drug Alias NameUBX-362

ClassificationSmall molecules > Proteolysis-Targeting Chimera (PROTAC)

Mechanisms of ActionABL proto-oncogene 1 degraders

TargetsABL proto-oncogene 1

Therapy Area/IndicationsLeukemia, Myelogenous, Chronic

Global Approved IndicationsN/A

Approved Indications in ChinaN/A

Original Approved Country/TerritoryN/A

Original Approved DateN/A

Country/TerritorySouth Korea

CombinationsNo

Global Highest StatusPreclinical

Highest Status in ChinaN/A

China Registration ClassN/A

Inactive CompaniesN/A

Active IndicationsLeukemia, Myelogenous, Chronic

Inactive IndicationsN/A

ATC CodeN/A